Song Yisu, Lu Zhengyang, Shu Wenzhi, Xiang Ze, Wang Zhengxin, Wei Xuyong, Xu Xiao
Department of Hepatobiliary and Pancreatic Surgery Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, 310006, China.
Zhejiang University School of Medicine, Hangzhou, China.
Cell Insight. 2023 Aug 11;2(5):100115. doi: 10.1016/j.cellin.2023.100115. eCollection 2023 Oct.
Liver diseases are a major health issue, and prolonged liver injury always progresses. Advanced liver disorders impair liver regeneration. Millions of patients die yearly worldwide, even with the available treatments of liver transplantation and artificial liver support system. With its abundant cell resources and significant differentiative potential, stem cell therapy is a viable treatment for various disorders and offers hope to patients waiting for orthotopic liver transplantation. Considering such plight, stem cell therapeutic strategies deliver hope to the patients. Moreover, we conclude intrinsic and acquired perspectives based on stem cell sources. The properties and therapeutic uses of these stem cells' specific types or sources were then reviewed. Owing to the recent investigations of the above cells, a safe and effective therapy will emerge for advanced liver diseases soon.
肝脏疾病是一个重大的健康问题,长期的肝损伤往往会不断发展。晚期肝脏疾病会损害肝脏再生。即使有肝移植和人工肝支持系统等现有治疗方法,全球每年仍有数百万人死亡。干细胞疗法凭借其丰富的细胞资源和显著的分化潜能,是治疗各种疾病的一种可行方法,为等待原位肝移植的患者带来了希望。考虑到这种困境,干细胞治疗策略给患者带来了希望。此外,我们基于干细胞来源总结了内在和后天的观点。然后回顾了这些特定类型或来源的干细胞的特性和治疗用途。由于最近对上述细胞的研究,一种安全有效的晚期肝病治疗方法很快就会出现。